Novavax Inc’s COVID-19 vaccine was 96 per cent effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval. There were no cases of severe illness or deaths among those who got the vaccine, the company said, in a sign that it could stop the worse effects of new variants that have cropped up. The vaccine was 86 per cent effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom, for a combined 90 per cent effectiveness rate overall based on data from infections of both versions of
Hence then, the article about covid 19 novavax vaccine highly effective in latest trial was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( COVID-19: Novavax vaccine highly effective in latest trial )